Melatonin in glioblastoma therapy: clinical promise and mechanistic insights from bench to bedside
- PMID: 41604009
- DOI: 10.1007/s10143-025-04121-9
Melatonin in glioblastoma therapy: clinical promise and mechanistic insights from bench to bedside
Keywords: Apoptosis; Drug synergism; GBM; MLT; Tumor microenvironment.
Conflict of interest statement
Declarations. Ethics approval: Not applicable. Competing interests: The authors declare no competing interests. Clinical trial number: Not applicable.
References
-
- Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-oncology 23(8):1231–1251. https://doi.org/10.1093/neuonc/noab106 - DOI - PubMed - PMC
-
- Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJB et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. New Engl J Med 352:987–96. https://doi.org/10.1056/NEJMoa043330 - DOI - PubMed
-
- Dirks PB (2010) Brain tumor stem cells: the cancer stem cell hypothesis writ large. Mol Oncol 4:420–430. https://doi.org/10.1016/j.molonc.2010.08.001 - DOI - PubMed - PMC
-
- Liebelt BD, Shingu T, Zhou X, Ren J, Shin SA, Hu J (2016) Glioma stem cells: signaling, microenvironment, and therapy. Stem Cells Int 2016:1–10. https://doi.org/10.1155/2016/7849890 - DOI
Publication types
LinkOut - more resources
Full Text Sources
